Last reviewed · How we verify
NCT05352113
Intradermal Needle Therapy for Major Depressive Disorder
NA trial testing SSRIs in Major Depressive Disorder in 120 participants. Status unknown.
1 May 2025
Quick facts
| Lead sponsor | The Third Affiliated hospital of Zhejiang Chinese Medical University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 1 May 2022 |
| Primary completion | 1 May 2025 |
| Estimated completion | 30 December 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- SSRIs — full drug profile →
- acupuncture — full drug profile →
- sham acupuncture
- placebo
Conditions studied
- Major Depressive Disorder — all drugs for Major Depressive Disorder →
Sponsor
The Third Affiliated hospital of Zhejiang Chinese Medical University
Who can join
Adults 12 to 60, any sex, with Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Major depressive disorder (MDD) is a common mental disorder that affects patients' physical health and quality of life. Although traditional acupuncture therapy has certain advantages in improving MDD, there are still some limitations, such as being time-consuming and some people having a fear of acupuncture. Therefore, intradermal needle therapy will be chosen in the treatment of MDD in this study, which is more convenient, shallow needling, and gentle than traditional acupuncture therapy. The study is designed to investigate the therapeutic effect and safety of intradermal needles for MDD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05352113
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of SSRIs
Trials testing the same drug.
- NCT07062666 — A Multicentre Clinical Study · not yet recruiting
- NCT06957223 — Efficacy of Dextromethorphan-Bupropion Versus SSRIs in the Treatment of Major Depressive Disorder · NA · active not recruiting
- NCT06957210 — Post-Traumatic Growth Following Eye Movement Desensitization and Reprocessing Therapy Versus SSRIs in Patients With Post · NA · active not recruiting
- NCT06358014 — Assessment of the Improvement in Cognitive Levels of Postmenopausal Depression Patients by Estrogen · NA · recruiting
- NCT05353543 — Acupuncture Therapy Based on Biological Specificity of Acupoints for Major Depressive Disorder · NA · unknown
Other recruiting trials for Major Depressive Disorder
Currently open trials in the same condition.
- NCT07219394 — Peer-Delivered Behavioral Activation in a CCBHC · NA · recruiting
- NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
- NCT06749392 — An Individual-specific Synchrony Signature · NA · recruiting
- NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
- NCT07242105 — Optimizing Brain Excitability in Depression · NA · recruiting
Other The Third Affiliated hospital of Zhejiang Chinese Medical University trials
Trials by the same sponsor.
- NCT07522567 — Efficacy of Acupuncture on Chronic Tinnitus and Its Association With Auditory Brainstem Response Measures · NA · not yet recruiting
- NCT07496580 — Efficacy Evaluation of Electroacupuncture in the Treatment of Functional Dyspepsia · NA · not yet recruiting
- NCT07325045 — Biomechanical Study of Lever Positioning Manipulation on Scoliosis · NA · not yet recruiting
- NCT07250308 — Correlation Study of Atrophic Gastritis and Dyspepsia Symptoms · recruiting
- NCT07308951 — Effect of Patient-Controlled Transcutaneous Electrical Acupoint Stimulation on Quality of Life in Chronic Cancer Pain · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05352113 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Third Affiliated hospital of Zhejiang Chinese Medical University
- Last refreshed: 28 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05352113.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing